| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | 10%+ Owner | Common Stock | 3,021,414 | $135,208,277 | $44.75 | 13 Sep 2024 | By Avalon BioVentures SPV I, L.P. |
| Janux Therapeutics, Inc. | 10%+ Owner | Common Stock | 2,959,175 | $132,423,081 | $44.75 | 13 Sep 2024 | By Avalon Ventures XI, L.P. |
| Janux Therapeutics, Inc. | 10%+ Owner | Common Stock | 573,227 | $25,651,908 | $44.75 | 13 Sep 2024 | By Avalon BioVentures I, LP |
| Janux Therapeutics, Inc. | 10%+ Owner | Common Stock | 7,000 | $326,760 | $46.68 | 13 Sep 2024 | Direct |
| OTONOMY, INC. | Director | Stock Option (right to buy) | 27,500 | 21 Jun 2022 | Direct | ||
| Janux Therapeutics, Inc. | 10%+ Owner | Stock Option (right to buy) | 7,682 | 13 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | 13 Sep 2024 | 9 | -$112,133 | 4 | 10%+ Owner | 24 Oct 2024, 16:15 |
| JANX | Janux Therapeutics, Inc. | 26 Jun 2024 | 2 | $0 | 4 | Director, 10%+ Owner | 28 Jun 2024, 16:30 |
| JANX | Janux Therapeutics, Inc. | 03 Jun 2024 | 3 | -$82,125,000 | 4 | Director, 10%+ Owner | 05 Jun 2024, 19:25 |
| JANX | Janux Therapeutics, Inc. | 13 Nov 2023 | 1 | +$4,988,643 | 4 | Director, 10%+ Owner | 15 Nov 2023, 16:46 |
| JANX | Janux Therapeutics, Inc. | 14 Jun 2023 | 1 | $0 | 4 | Director, 10%+ Owner | 16 Jun 2023, 17:10 |
| /report/000120919122038889-lichter-jay-2022-06-21 | OTONOMY, INC. | 21 Jun 2022 | 1 | $0 | 4 | Director | 23 Jun 2022, 16:34 |
| JANX | Janux Therapeutics, Inc. | 14 Jun 2022 | 1 | $0 | 4 | Director, 10%+ Owner | 16 Jun 2022, 16:31 |
| /report/000120919121043073-lichter-jay-2021-06-22 | OTONOMY, INC. | 22 Jun 2021 | 1 | $0 | 4 | Director | 24 Jun 2021, 17:02 |
| JANX | Janux Therapeutics, Inc. | 15 Jun 2021 | 11 | +$10,699,987 | 4 | Director, 10%+ Owner | 16 Jun 2021, 18:05 |
| JANX | Janux Therapeutics, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 14 Jun 2021, 17:37 |
| JANX | Janux Therapeutics, Inc. | 10 Jun 2021 | 0 | $0 | 3 | Director, 10%+ Owner | 10 Jun 2021, 19:12 |